| abstract |
The present disclosure relates to an IL-6R antibody, an antigen-binding fragment thereof, and medical uses. Further, the present disclosure relates to an alpaca-derived antibody, a chimeric antibody, a humanized antibody including the CDR region of the IL-6R antibody, and a medicinal composition including the IL-6R antibody and an antigen-binding fragment thereof, and its use as a medicament use. In particular, the present disclosure relates to the use of a humanized IL-6R antibody in the manufacture of a medicament for the treatment of an IL-6 related disease or disorder. |